Related Experiment Video
Updated: Jul 4, 2025

Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
Methylphenidate Ameliorates Behavioural and Neurobiological Deficits in Executive Function for Patients with Chronic
Alexander R D Peattie1,2, Anne E Manktelow1,2, Barbara J Sahakian3
1Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Box 93, Hills Road, Cambridge CB2 0QQ, UK.
Methylphenidate (MPh) improved cognitive function in traumatic brain injury (TBI) patients, enhancing visuospatial planning and executive function. This study investigated MPh's neurobiological effects on TBI recovery.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Clinical Neurology
Background:
- Traumatic brain injury (TBI) frequently causes cognitive deficits, particularly in visuospatial planning and executive functions.
- Methylphenidate (MPh) shows promise in ameliorating cognitive impairments in TBI patients.
- The Tower of London (TOL) task assesses executive function and visuospatial planning abilities.
Purpose of the Study:
- To investigate the neurobiological underpinnings of visuospatial planning and executive function in TBI patients.
- To examine the effects of Methylphenidate (MPh) on cognitive performance and brain activity in individuals with TBI.
- To compare brain activity and connectivity in TBI patients with and without MPh treatment against healthy controls.
Main Methods:
- A randomized, double-blinded, placebo-controlled fMRI study involving individuals with a history of TBI.
- Participants completed the Tower of London (TOL) task under conditions with and without MPh.
- Neuroimaging data (fMRI) were analyzed to assess brain activity and functional connectivity during task performance.
Main Results:
- TBI patients on placebo exhibited significant deficits in reaction time and accuracy compared to healthy controls, especially on high cognitive load tasks.
- MPh treatment improved accuracy in TBI patients to levels comparable to healthy controls across various cognitive loads.
- MPh normalized reduced activity in the inferior frontal gyri and insulae observed in TBI patients and enhanced specific brain network connectivity, correlating with improved accuracy.
Conclusions:
- Individuals with chronic TBI exhibit distinct behavioral and neurofunctional patterns compared to healthy controls.
- Methylphenidate (MPh) treatment can significantly improve cognitive performance, particularly visuospatial planning and executive functions, in TBI patients.
- MPh positively modulates brain activity and connectivity, offering a potential therapeutic avenue for cognitive deficits post-TBI.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Role of Cerebellum and Prefrontal Cortex in Memory

